GIA
IMVT icon

GHP Investment Advisors’s Immunovant IMVT Stock Holding History

GHP Investment Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78 Hold
2
– – ﹤0.01% 1309
2026
Q1 		$50 Buy
+2
New +$52 ﹤0.01% 1372

Other funds holding IMVT

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $213M AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

GHP Investment Advisors's IMVT Position: Q2 2026 in Review

GHP Investment Advisors held its Immunovant (IMVT) position steady in Q2 2026 at 2 shares worth $78. The position accounts for ﹤0.01% of the portfolio, ranked #1309.

GHP Investment Advisors first reported a position in IMVT in Q1 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • GHP Investment Advisors held 2 shares of Immunovant worth $78 as of Q2 2026.
  • GHP Investment Advisors left its Immunovant share count unchanged in Q2 2026.
  • Immunovant made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1309 holding.
  • GHP Investment Advisors first reported a position in Immunovant in Q1 2026 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.